fda warning letters glp-1 september 2025 news issued 25 to telehealth companies for false and misleading claims about compounded products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of FDA issues 30 warning letters
Description
doi: 10.3803/EnM.2016.31.2.258
Turning GLP-1 Into a Sustainable Lifestyle Tool GLP-1 medications can be life-changing, but they are most effective when paired with intentional nutrition
A recent study involving 3,390 people taking semaglutide or liraglutide found participants who took high doses of their drug 1.7 mg, 2.0 mg or 2.4 mg of semaglutide, or 3 mg of liraglutide lost more weight after a year compared to people taking lower doses
Ratner RE, Rosenstock J, Boka G
Why it matters: Microdoses of GLP-1s are not FDA approved, but the ad hoc practice of smaller doses began taking off on social media last year
